Contact
Please use this form to send email to PR contact of this press release:
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
TO:
Please use this form to send email to PR contact of this press release:
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
TO: